Cefdinir Pregnancy and Breastfeeding Warnings
Brand names: Omnicef, Omnicef Omni-Pac
Medically reviewed by Drugs.com. Last updated on Aug 4, 2023.
Cefdinir Pregnancy Warnings
Cefdinir has been assigned to pregnancy category B by the FDA. Animal studies have revealed evidence of maternal toxicity (decreased body weight gain) and decreased fetal body weight. There are no controlled data in human pregnancy. Cefdinir should be given during pregnancy only if need is clearly established.
Cefdinir Breastfeeding Warnings
Following administration of single 600 mg doses, cefdinir has not been detected in human breast milk. Other cephalosporins have been classified as compatible with breast-feeding by the American Academy of Pediatrics.
See also
References for pregnancy information
- (2001) "Product Information. Omnicef (cefdinir)." Parke-Davis
References for breastfeeding information
- (2001) "Product Information. Omnicef (cefdinir)." Parke-Davis
- Briggs GG, Freeman RK, Yaffe SJ.. (1998) "Drugs in Pregnancy and Lactation." Baltimore, MD: Williams & Wilkins
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
